Anthropic IPO: demand six times supply as Chinese investors are excluded
Prepared by Sintelligent with the help of SI. Published in SI: . Updated: .
Anthropic's offering combines exceptional demand with geographic restrictions on investor access: technology controls and export rules are shaping not only the laboratory's products but also its capital structure.
According to Bloomberg, orders for Anthropic shares were approximately six times the number available. The company intends to raise up to $64.4 billion on Nasdaq and another $26 billion through a private placement at a target valuation of about $1.4 trillion. The public offering covers 825 million shares priced at $70–78, with trading under the ANT ticker scheduled to begin on November 19. According to The Decoder, Anthropic's annualized revenue grew from $71 billion in September to $81 billion by the end of October, while Nvidia is participating in the private placement with $10 billion. Bloomberg later reported that several banks are rejecting orders from institutional investors in mainland China and Hong Kong or consider allocations to them unlikely, citing US ITAR rules. Goldman Sachs and Morgan Stanley are leading the offering alongside 20 other banks; Anthropic declined to comment on the restrictions.